Detalles de la búsqueda
1.
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.
Oncology
; 68(4-6): 326-32, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16020959
2.
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 106(12): 3725-32, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16123223
Resultados
1 -
2
de 2
1
Próxima >
>>